Advertisement
Forex Nyheter
DiaMedica Appoints Lorianne Masuoka As Chief Medical Officer
Biopharmaceutical company DiaMedica Therapeutics Inc. (DMAC) announced Monday the appointment of Lorianne Masuoka as Chief Medical Officer. Masuoka is a board-certified neurologist with more than 25 years of experience in managing clinical programs from early stage to drug approvals and strategic alliances.
RTTNews |
573 dagar sedan
Seelos Therapeutics Says Received Minutes From End Of Phase II Meeting With FDA
Biopharmaceutical company Seelos Therapeutics, Inc. (SEEL) announced Monday the receipt of minutes from its End of Phase II Meeting with the U.S. Food and Drug Administration or FDA that highlights the modifications to the primary and secondary endpoints of its Phase II Study of SLS-002.
RTTNews
|
573 dagar sedan
Resilient Consumer Spending Data Lifts Dollar Again Last Week
The U.S. Dollar strengthened against major currencies during the week ended January 19 amidst strong Retail Sales data from the U.S. that implied resilient consumer spending despite high interest rates.
RTTNews
|
573 dagar sedan
Sunoco To Acquire NuStar Energy In $7.3 Bln All-equity Deal
Sunoco LP (SUN) and NuStar Energy L.P. (NS) announced Monday that the parties have entered into a definitive agreement whereby Sunoco will acquire NuStar in an all-equity transaction valued at approximately $7.3 billion, including assumed debt.
RTTNews
|
573 dagar sedan
Pharvaris Says FDA Lifts Clinical Hold On IND For Deucrictibant For Treatment Of HAE Attacks
Clinical-stage company Pharvaris N.V. (PHVS) announced Monday the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Investigational New Drug (IND) application for deucrictibant for the prophylactic treatment of HAE attacks following review of data from a 26-week rodent toxicology study.
RTTNews
|
573 dagar sedan
Bay Street Likely To Inch Higher In Cautious Trade
Canadian shares are likely to open higher on Monday, tracking firm crude oil prices and steady European markets. With the Bank of Canada's monetary policy announcement due on Wednesday, the mood is likely to remain a bit cautious.
RTTNews
|
573 dagar sedan
AstraZeneca Says AIRSUPRA Now Commercially Available In US As FDA-approved Option For Asthma
AstraZeneca (AZN, AZN.L) announces Monday that AIRSUPRA (albuterol/budesonide) is now commercially available in the US by prescription. AIRSUPRA was approved based on the results from two Phase III trials, MANDALA and DENALI.
RTTNews
|
573 dagar sedan
more news
Bank Of Hawaii Q4 Profit Halves, Misses Estimates
Bank of Hawaii Corp. (BOH) reported Monday that net income available to common shareholders for the fourth quarter decreased to $28.43 million or $0.72 per share from $59.34 million or $1.50 per share in the prior-year quarter.
RTTNews
|
573 dagar sedan
European Shares Edge Higher With ECB Meeting In The Spotlight
European stocks were moving higher on Monday as investors looked ahead to the European Central Bank monetary policy decision on Thursday to ascertain the timing and pace of interest-rate cuts this year.
RTTNews
|
573 dagar sedan
FTSE 100 Slightly Higher In Cautious Trade
U.K. stocks were seeing modest gains on Monday, buoyed by strong gains on Wall Street overnight led by chipmakers and technology stocks.
RTTNews
|
573 dagar sedan
CAC 40 Rallies As Markets Look For Clues From ECB Meeting
French stocks climbed on Monday as investors looked ahead to the European Central Bank monetary policy decision on Thursday to ascertain the timing and pace of interest-rate cuts this year.
RTTNews
|
573 dagar sedan
DAX Gains After Wall Street Rally
German stocks were notably higher on Monday after the benchmark S&P 500 hit a record peak on Friday, fueled by a rally in U.S. chipmakers and heavyweight technology stocks.
RTTNews
|
573 dagar sedan
Asian Shares Mixed; Chinese And Hong Kong Lead Losses
Asian stocks ended Monday's session on a mixed note as concerns over China's faltering economy offset dovish BOJ bets.
RTTNews
|
573 dagar sedan
Stay up to date!
Add Nyheter to your browser
Add To Chrome
